MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4

Rhea-AI Filing Summary

MeiraGTx Holdings plc chief medical officer Robert K. Zeldin reported equity award activity involving restricted share units and ordinary shares. On February 21, 2026, one quarter of a restricted share unit grant from February 21, 2023 vested, converting 7,500 restricted share units into 7,500 ordinary shares at no cash exercise price. In connection with this vesting, 2,952 ordinary shares were automatically withheld at a price of $7.45 per share to cover tax obligations, a tax-withholding disposition rather than an open-market sale. After these transactions, Zeldin directly held 172,888 ordinary shares.

Insider Trade Summary

7,500 shares exercised/converted

Mixed 3 txns

Insider Zeldin Robert K

Role CHIEF MEDICAL OFFICER

Type	Security	Shares	Price	Value
Exercise	Restricted Share Units	7,500	$0.00	--
Exercise	Ordinary Shares	7,500	$0.00	--
Tax Withholding	Ordinary Shares	2,952	$7.45	$22K

Holdings After Transaction: Restricted Share Units — 7,500 shares (Direct); Ordinary Shares — 175,840 shares (Direct)

Footnotes (1)

1. Represents vesting of one-quarter of restricted share units granted on February 21, 2023. Each restricted share unit converts into one ordinary share upon vesting. Shares withheld for payment of taxes upon vesting of award.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zeldin Robert K

(Last) (First) (Middle)

655 THIRD AVENUE

SUITE 1115

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MeiraGTx Holdings plc [ MGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF MEDICAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/21/2026		M		7,500(1)	A	(2)	175,840	D
Ordinary Shares	02/21/2026		F		2,952(3)	D	$7.45	172,888	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(2)	02/21/2026		M			7,500	(1)	(1)	Ordinary Shares	7,500	$0	7,500	D

Explanation of Responses:

1. Represents vesting of one-quarter of restricted share units granted on February 21, 2023.

2. Each restricted share unit converts into one ordinary share upon vesting.

3. Shares withheld for payment of taxes upon vesting of award.

	/s/ Robert J. Wollin, Attorney-in-fact for Robert K. Zeldin	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MeiraGTx (MGTX) report for Robert K. Zeldin?

MeiraGTx reported that chief medical officer Robert K. Zeldin had 7,500 restricted share units vest and convert into 7,500 ordinary shares. As part of this vesting, 2,952 shares were withheld to satisfy tax obligations, leaving him with 172,888 ordinary shares directly held.

Was the MeiraGTx (MGTX) Form 4 a stock sale by Robert K. Zeldin?

The Form 4 primarily reflects equity award vesting, not an open-market stock sale. Zeldin received 7,500 ordinary shares from vested restricted share units, while 2,952 shares were withheld at $7.45 per share only to cover associated tax liabilities.

How many MeiraGTx (MGTX) shares did Robert K. Zeldin own after the reported transactions?

Following the vesting and related tax withholding, Robert K. Zeldin directly owned 172,888 MeiraGTx ordinary shares. This figure reflects the 7,500 shares received from restricted share unit vesting, net of the 2,952 shares withheld to satisfy tax obligations on the vesting event.

What equity award vested for Robert K. Zeldin at MeiraGTx (MGTX)?

The filing states that one quarter of a restricted share unit award granted on February 21, 2023 vested. Each restricted share unit converted into one MeiraGTx ordinary share, resulting in 7,500 new ordinary shares credited to Robert K. Zeldin upon vesting.

What does the tax-withholding transaction mean in the MeiraGTx (MGTX) Form 4?

The tax-withholding transaction, coded “F,” shows 2,952 ordinary shares delivered at $7.45 per share to pay taxes due on the vesting. This represents a tax-liability settlement using shares, not a discretionary open-market sale by Robert K. Zeldin.